My biggest hope is as clinicians, you will incorporate the “Explain-Name-Validate” framework into your interactions with patients and their families and teach it to your colleagues and students.
https://t.co/y1VfqeRTMh
Let me tell you a story about 2 patients we identified via a research study, both with a rare variant in the cardiac troponin T gene, TNNT2; NM_001001430.3: c.571-1G>A. Both had cardiac phenotypes and both had Oceanian ancestry /1
High five to incoming PhD student @SophieHespe for this nice case series of our experiences with FLNC truncating variants. From secondary findings, to highly arrhythmic presentations - this gene tests our expertise in many ways! @bdebneygray 👏 https://t.co/iK3tPbICUJ
The Trouble with Trabeculation: How Genetics Can Help to Unravel a Complex and Controversial Phenotype - new review article, online now at JCTR, describing the genetic basis of LVNC and the diagnostic utility of genetic testing https://t.co/hw8NC2oAZr
Finally - balanced, clear and concise insights to help you understand polygenic scores, the complexities of implementation and potential solutions. Open to all
https://t.co/1HcXM6wmYc
Although being rapidly incorporated into health care, there are currently no clinical guidelines available for the use of this technology. @TheACMG points to consider document via @GIMJournal https://t.co/udt7vFfklU
I lost a dear patient over the weekend, but not before they participated in a celebration of life where they heard firsthand just how much they mattered to their loved ones
If you truly care about someone, tell them while you can
This is not a rehearsal
#MondayMotivation
The study found that LQT2 patients with non-missense variants of KCNH2 had better clinical outcomes than those with missense variants. These findings could impact treatment options by guiding genetic testing and personalized therapy for LQT2 patients. #cardiotwitter @SADSFoundation #cardiogen #SADS #lqts
https://t.co/9PXtAKfj8d
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant
@Circ_Gen
https://t.co/ARjL2ieBuG
Hey #GeneChat I have some thoughts about #IAmAGeneticCounselor, with some personal sharing to do by way of background.
Last year I hit a low point, but thanks to the support of my GP, a psychologist, an anti-anxiety pill, and 6 weeks off work, I'm starting 2023 off much better.
FINALLY able to share with you our latest! You know those papers that make you lose the will to live but also feel so damned proud? 🥲 Well this is mine, and i’m so excited to finally share it. Let me tell you about desmoplakin! @circ_gen#circgen https://t.co/BJEvdHw32I /1
In a retrospective analysis of pts w familial hypercholesterolemia, maternal vs paternal inheritance yielded ↑ burden of subclinical athero.
Supports hypothesis that in utero exposure to maternal ↑chol may have long-term consequences https://t.co/0j7X3Wbs9C @atvbahajournals